Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $83.0100 (6.11%) ($78.0000 - $85.0000) on Wed. Apr. 8, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.99% (three month average) | RSI | 51 | Latest Price | $83.0100(6.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 4% a day on average for past five trading days. | Weekly Trend | LGND advances 2.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(56%) IWO(53%) XBI(52%) IWC(49%) IWM(48%) | Factors Impacting LGND price | LGND will decline at least -2.995% in a week (0% probabilities). VIXM(-26%) VXX(-16%) UUP(-16%) TLT(-3%) UNG(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.995% (StdDev 5.99%) | Hourly BBV | 0 () | Intraday Trend | 5.7% | | | |
|
5 Day Moving Average | $76.77(8.13%) | 10 Day Moving Average | $73.81(12.46%) | 20 Day Moving Average | $74.27(11.77%) | To recent high | -23.1% | To recent low | 31% | Market Cap | $1.334b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |